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Abstract: Differences in body fat distribution may be a reason for the sex-, age-, and ethnicity-related
differences in the prevalence of fatty liver disease (FL). This study aimed to evaluate the sex- and
age-related differences in the contribution of visceral (VAT) and subcutaneous (SAT) abdominal fat,
measured by ultrasound, to fatty liver index (FLI) in a large sample of overweight and obese Caucasian
adults, and to identify the VAT and SAT cut-off values predictive of high FL risk. A cross-sectional
study on 8103 subjects was conducted. Anthropometrical measurements were taken and biochemical
parameters measured. VAT and SAT were measured by ultrasonography. FLI was higher in men
and increased with increasing age, VAT, and SAT. The sex*VAT, age*VAT, sex*SAT, and age*SAT
interactions negatively contributed to FLI, indicating a lower VAT and SAT contribution to FLI
in men and in the elderly for every 1 cm of increment. Because of this, sex- and age-specific
cut-off values for VAT and SAT were estimated. In conclusion, abdominal adipose tissue depots
are associated with FLI, but their contribution is sex- and age-dependent. Sex- and age-specific
cut-off values of ultrasound-measured VAT and SAT are suggested, but they need to be validated in
external populations.
Keywords: fatty liver disease; fatty liver index; visceral adipose tissue; subcutaneous adipose tissue;
obesity; ultrasonography
1. Introduction
Fatty liver disease (FL) is the most common chronic liver disease in Western countries [1], and is
characterized by an excessive accumulation of fat in the liver. It is usually divided into alcoholic
fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD) [2]. The diagnosis of FL is
made through imaging procedures or liver histology. Moreover, Bedogni et al. established a formula
to calculate the fatty liver index (FLI) based on routine clinical measurements like body mass index
(BMI), waist circumference (WC), triglycerides (TG), and gamma-glutamyltrasnferase (GGT) to predict
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ultrasonographic FL [3]. This simple, not expensive, non-invasive, and cross-validated [4,5] algorithm
has excellent discriminative ability to identify subjects at higher risk of FL.
In the Italian general population, the prevalence of FL is 45–46% [1,3,6]. However, sex-, age-, and
ethnicity-related FL prevalence have been reported [7–11]. Many studies have reported that the male
sex has a higher risk for FL, with a doubled prevalence compared to women [10,12]. Furthermore,
a number of studies have shown that the prevalence of FL increases with age, and that Hispanic
individuals, compared to non-Hispanic whites, have a higher prevalence of FL, and non-Hispanic
blacks a lower prevalence [13]. Sex-, age-, and ethnicity-related differences in body fat distribution
may be one reason for the differences in FL prevalence observed in these different subject groups.
Obesity, both general and visceral obesity, is most probably the main risk factor for FL [13].
However, it is well known that there are sex-, age-, and ethnicity-related differences in the distribution
of adipose tissue, particularly in the abdominal compartments. For instance, at the same degree of
obesity, women have 10% higher body fat compared to men. Moreover, at the same level of total
adiposity, estimated either by BMI or by imaging techniques, women have more abdominal and
gluteal–femoral subcutaneous adipose tissue (SAT) than men, who show higher visceral adipose tissue
(VAT). Aging, for its part, increases adiposity in both sexes. Indeed, aging is associated with increased
VAT accumulation [14]. This increase is greater in women, almost quadrupling between the ages of
25 and 65 years, whereas in men, it is only slightly more than doubled [14]. In contrast, SAT, despite
an initial increase with increasing age, starts to decline after 50 years in men and after 60 years in
women [15]. Finally, white men store more fat as VAT than black men, while no such difference has
been reported for women. However, SAT has been found to be higher in black women than in white, a
difference not reported for men [16]. Nevertheless, there have been few studies investigating sex- and
age-related differences in the contribution of abdominal fat compartments to FL.
Imaging techniques like computed tomography and magnetic resonance imaging are the reference
methods used for the assessment of body fat compartments [15]. However, because they are expensive
and because computed tomography exposes the patient to ionizing radiation, imaging techniques are
not often applied in routine clinical practice and large epidemiological studies. Given its low cost and
simplicity, waist circumference (WC) is the most clinically used surrogate measure of abdominal fat.
However, it does not allow separate assessment of VAT and SAT contributions. Ultrasonography (US),
however, offers a low-cost, reproducible, reliable, and non-invasive alternative to the gold standard
imaging techniques [15].
In the present study, we evaluated, in a large sample of overweight and obese Caucasian adults,
the contribution of sex- and age-related differences in ultrasound-measured VAT and SAT to FL. We also
identified sex- and age-specific VAT and SAT cut-off values for the identification of subjects at high
FL risk.
2. Materials and Methods
2.1. Study Design and Procedures
We carried out a cross-sectional study on 8316 consecutive overweight and obese Caucasian adults
who voluntary referred to the International Center for the Assessment of Nutritional Status (University
of Milan, Milan, Italy) between September 2010 and February 2019 for participation in a structured
weight loss program.
Each participant was subjected to a clinical examination, an anthropometric assessment, blood tests,
and an ultrasound measurement of VAT and SAT, all on the same day. Their smoking status and
physical activity level were investigated through a structured interview. Subjects who spent ≥2 h/week
in any structured physical activity were considered physically active [17]. Excluded from the study
were participants younger than 18 years; those with diagnosed infective, cardiac, neurological,
gastrointestinal, pulmonary, or renal disease; those with previous diagnoses of hepatitis B and C; those
using medications known to cause lipodystrophy (e.g., steroids and antiretroviral agents); and those
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who had been subjected to surgery in the abdominal area. From the 8316 participants initially recruited,
we excluded those with missing values on one of the variables of interest (142) and those with VAT
and SAT higher than 14 cm, because of the difficulty of measurement (71). A total 8103 subjects were
included in the final dataset. The study was conducted according to the guidelines laid down in the
Declaration of Helsinki, and all procedures involving human participants were approved by the ethics
committee of the University of Milan (report n. 23/2016). Written informed consent was obtained from
all participants.
2.2. Clinical and Anthropometrical Examination
Detailed medical interviews were conducted to investigate the clinical history of the patients
and their current drug therapies. Anthropometric measurements were taken following international
guidelines [18]. Body weight was measured to the nearest 100 g with a column scale (Seca 700 balance,
Seca Corporation) and with participants wearing only light underwear. Body height was measured
to the nearest 0.1 cm using a vertical stadiometer. BMI was calculated as weight (kg)/height (m)2
and classified as follows: overweight = BMI 25.0–29.9, obese = BMI ≥ 30. WC was measured at the
midpoint between the last rib and the iliac crest with a non-stretch tape to the nearest 0.5 cm.
2.3. Abdominal Ultrasonography
Abdominal ultrasonography was carried out on the fasting patients by the same physician, using a
Logiq 3 Pro instrument equipped with a 7.5 MHz linear probe and with a 3.5 MHz convex-array probe
(GE Healthcare). VAT and SAT were measured 1 cm above the umbilicus. The measurements were
taken at the end of expiration and applying a standardized probe pressure. SAT, measured with the
7.5 MHz linear probe, was defined as the distance between the epidermis and the external face of
the rectus abdominis muscle; VAT, measured with the 3.5 MHz convex-array probe, was defined as
the distance between the anterior wall of the aorta and the posterior surface of the rectus abdominis
muscle [19,20]. Each measurement was taken three times and the mean of the three measurements was
entered into the database.
2.4. Blood Sampling and Fatty Liver Index Determination
Fasting blood samples were obtained between 8:30 and 9:00 AM and immediately analyzed at the
ICANS laboratory. Triglycerides and GGT were measured by means of an enzymatic method (Cobas
Integra 400 Plus, Roche Diagnostics, Rotkreuz, Switzerland).
Fatty liver index was calculated using the following formula [3]:
FLI = (e0.953 × loge (triglycerides) + 0.139 × BMI + 0.718 × loge (ggt) + 0.053×waist circumference − 15.745)/
(1 + e0.953 × loge (triglycerides) + 0.139 × BMI + 0.718 × loge (ggt) + 0.053 × waist circumference − 15.745) × 100
FLI varies between 0 and 100, and a FLI ≥ 60 has been associated with a high probability of FL [3].
2.5. Statistical Analysis
Many continuous variables followed a non-Gaussian distribution and all are reported herein as
25th, 50th, and 75th percentiles. Discrete variables are reported as numbers and frequencies. In order to
limit the influence of outliers, we winsorized, using a tail of 0.01, all continuous variables besides age.
This means that values under the 1st or over the 99th internal percentile were set as equal to the 1st or
99th internal percentile, respectively. This limitation of the influence of outliers is an important strategy
to increase the generalizability of regression models [20]. Linear regression models were used to assess
the association of VAT and SAT with FLI. Included in the models as predictors were sex (discrete,
0 = women, 1 = men), age (continuous), smoking (discrete; 0 = never smoked, 1 = former smoker,
2 = smoker), and structured physical activity (discrete; 0 = no, 1 = yes). Sex and age interactions
with SAT and VAT were also included in the model. We used multivariable fractional polynomials to
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model the non-linear associations of continuous predictors with the outcome. Using this approach,
we found that a square root transformation of VAT/10 (VAT/10)0.5 and a squared transformation of
SAT (SAT2) ensured better fits for the model. A receiver operating characteristic (ROC) curve analysis
was used to develop a cut-off for VAT and SAT associated with the presence of high probability of FL
(FLI ≥ 60). We performed exploratory subgroup analysis to obtain the sex- and age-specific cut-off
values. We evaluated the cut-off indexes for VAT and SAT that maximized the Youden index (sensitivity
+ specificity−1). A p-value < 0.05 was considered statistically significant. Statistical analysis was
performed using STATA version 12.0 (StataCorp, College Station, TX, USA).
3. Results
The general characteristics of the study population are reported in Table 1
Table 1. General characteristics of the study population.
Women Men Total
n = 5530 n = 2573 n = 8103
P25 P50 P75 P25 P50 P75 P25 P50 P75
Age (years) 39 48 57 40 48 57 39 48 57
BMI (kg/m2) 27.3 29.8 33.6 28.2 30.7 33.7 27.5 30.1 33.7
Waist circumference (cm) 90.3 97.0 105.4 101.0 107.8 116.2 92.9 100.6 109.7
SAT (cm) 2.3 3.0 3.8 2.0 2.7 3.5 2.2 2.9 3.8
VAT (cm) 3.5 4.9 6.7 5.9 7.7 9.6 4.0 5.7 7.9
Triglycerides (mg/dL) 67 90 125 87 122 174 72 99 140
GGT (U/L) 12 17 24 22 31 46 14 20 32
Fatty Liver Index 26.8 49.6 77.0 60.3 80.5 92.3 33.9 61.2 84.9
n % n % n %
Age classes
18–19 years 73 1.3 22 0.9 95 1.2
20–29 years 481 8.7 156 6.1 637 7.9
30–39 years 941 17.0 461 17.9 1402 17.3
40–49 years 1525 27.6 771 30.0 2296 28.3
50–59 years 1383 25.0 627 24.4 2010 24.8
60–69 years 800 14.5 402 15.6 1202 14.8
≥70 years 327 5.9 134 5.2 461 5.7
Total 5530 100.0 2573 100.0 8103 100.0
BMI classes
Overweight 2845 51.4 1094 42.5 3939 48.6
Obese 2685 48.6 1479 57.5 4164 51.4
Total 5530 100.0 2573 100.0 8103 100.0
FLI classes
0–9.9 163 2.9 3 0.1 166 2.0
10–19.9 709 12.8 37 1.4 746 9.2
20–29.9 737 13.3 82 3.2 819 10.1
30–39.9 625 11.3 118 4.6 743 9.2
40–49.9 562 10.2 180 7.0 742 9.2
50–59.9 523 9.5 217 8.4 740 9.1
60–69.9 500 9.0 265 10.3 765 9.4
70–79.9 489 8.8 365 14.2 854 10.5
80–89.9 556 10.1 513 19.9 1069 13.2
90–100 666 12.0 793 30.8 1459 18.0
Total 5530 100.0 2573 100.0 8103 100.0
Risk of fatty liver disease
<60 3320 60.0 637 24.8 3957 48.8
≥60 2210 40.0 1936 75.2 4146 51.2
Total 5530 100.0 2573 100.0 8103 100.0
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In our population, 51.2% of subjects were at high risk for FL (FLI ≥ 60). The FL frequency was
significantly higher in men (OR = 13.9, 95%CI: 11.8, 16.4, p < 0.001) and increased with increasing age
(OR = 1.04, 95%CI: 1.04, 1.05, p < 0.001 per year) and BMI (OR = 2.0, 95%CI: 2.0, 2.1, p < 0.001 per kg/m2).
Table 2 reports the contribution of VAT and SAT to FLI, taking into account sex, age, lifestyle
indexes and their interactions with abdominal fat depots.
Table 2. Association of visceral and subcutaneous abdominal fat with fatty liver index.
Fatty Liver Index Fatty Liver Index
Sex (male) 26.95 *** 29.27 ***
[22.21,31.69] [27.67,30.87]





Smoker 1.21 * 2.98 ***
[0.17,2.25] [1.76,4.20]
Physical activity (yes) −3.63 *** −7.12 ***
[−4.51,−2.75] [−8.12,−6.13]
(VAT/10)0.5 144.18 *** −
[135.42,152.93]
Sex*(VAT/10)0.5 −25.80 *** −
[−31.07,−20.53]
Age*(VAT/10)0.5 −0.58 *** −
[−0.75,−0.41]
SAT2 − 2.32 ***
[2.10,2.53]
Sex*SAT2 − −0.46 ***
[−0.57,−0.35]
Age*SAT2 − −0.02 ***
[−0.02,−0.01]
Intercept −49.29 *** −4.4 **
[−56.17,−42.40] [−7.48,−1.33]
Observations 8103 8103
Values are linear regression coefficients and 95% confidence interval (in brackets). Abbreviations: * p < 0.05,
** p < 0.01, *** p < 0.001.
Being male and habitual smoking increased the value of FLI, while being physically active
decreased it. Moreover, FLI increased with increasing age, VAT, and SAT. The sex*VAT, age*VAT,
sex*SAT, and age*SAT interactions negatively contributed to FLI, indicating a lower VAT and SAT
contribution to FLI in men and in the elderly for every 1 cm of increment.
Given the sex and age differences in the contribution of VAT and SAT to FLI, we estimated the sex-
and age-specific cut-off values for VAT and SAT by dividing subjects into different categories based on
birth sex and age decade (Table 3).
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Table 3. Sex- and age-specific cut-off values of VAT and SAT predicting a high risk of fatty liver.
Sex Age (Years) n Optimal Cutoff
VAT SAT
VAT (VAT/10)0.5 SN 1-SP AUC SAT SAT2 SN 1-SP AUC
Women
18–29 554 4.40 0.66 0.65 0.14 0.812 3.86 14.90 0.82 0.27 0.857
30–39 941 4.79 0.69 0.69 0.20 0.811 3.41 11.63 0.76 0.34 0.775
40–49 1525 4.88 0.70 0.81 0.26 0.844 3.23 10.43 0.69 0.31 0.747
50–59 1383 5.60 0.75 0.76 0.21 0.848 3.00 9.00 0.65 0.38 0.666
60–69 800 6.72 0.82 0.65 0.14 0.831 2.79 7.78 0.55 0.32 0.647
≥70 327 7.08 0.84 0.70 0.22 0.816 1.87 3.50 0.75 0.65 0.548
Men
18–29 178 5.79 0.76 0.71 0.17 0.821 3.08 9.49 0.83 0.33 0.830
30–39 461 6.34 0.80 0.70 0.29 0.770 3.04 9.24 0.70 0.25 0.757
40–49 771 6.83 0.83 0.72 0.19 0.836 3.47 12.04 0.37 0.11 0.651
50–59 627 7.4 0.86 0.74 0.26 0.816 3.13 9.80 0.33 0.12 0.618
60–69 402 8.19 0.90 0.69 0.15 0.829 2.57 6.60 0.32 0.18 0.528
≥70 134 8.10 0.90 0.74 0.40 0.697 2.84 8.07 0.13 0.03 0.487
Abbreviations: VAT = visceral adipose tissue; SAT = subcutaneous adipose tissue; SN = sensitivity; SP = specificity;
AUC = area under curve.
VAT cut-offs were higher in men and increased with increasing age in both sexes.
In contrast, SAT cut-offs were similar between the sexes and decreased with increasing age.
Moreover, in postmenopausal women, SAT optimal cut-offs suffered low specificity and AUC. In men
aged ≥40 years, SAT optimal cut-offs, instead, suffered low sensitivity and AUC.
4. Discussion
In this study, we investigated the sex- and age-related contributions of abdominal fat depots to FLI
in a large sample of overweight and obese Caucasian subjects, and identified sex- and age-specific cut-off
values for high probability of FL. Overall, both VAT and SAT were associated with FLI, in agreement
with previous studies reporting a relationship between abdominal fat deposits and risk of FL [21];
however, the contributions differed between sexes and across ages.
Obesity, especially abdominal obesity, plays a pivotal role in the development of FL [22]. Excess
of abdominal fat leads to an enhanced lipolysis and increased flux of free fatty acids (FFA) towards the
liver through portal circulation [22]. Increased hepatic FFA induces increased hepatic lipogenesis and
gluconeogenesis [23], as well as decreased insulin clearance, resulting in hyperinsulinemia and insulin
resistance [23,24]. Insulin, in turn, promotes de novo lipogenesis [25], contributing to the synthesis of
hepatic triglycerides and the promotion of FL [26]. Moreover, the excess of abdominal fat alters the
expression and secretion of inflammatory cytokines, like tumor necrosis factor (TNF)-a, interleukin
(IL)-6, and IL-8, and of some adipokines, like leptin and adiponectin, also involved in the pathogenesis
of FL [21,22]. Indeed, inflammatory cytokines contribute to the activation of Kupffer cells and are
responsible for the transformation and perpetuation of hepatic stellate cells to the myofibroblastic
phenotype [27,28]. Adiponectin and leptin act respectively, regulating whole-body glucose homeostasis
and hepatic insulin sensitivity [29] and promoting fibrogenesis in stellate cells by stimulating the
production of fibrogenic genes and inflammation in T cells [30,31]. Evidence shows that VAT is
characterized by a higher rate of lipolysis than SAT [32], and thus it contributes more to excessive fatty
acid deposition in the liver, with subsequently increased hepatic glucose production, hyperinsulinemia,
and hypertriglyceridemia [33]. Additionally, the expression of inflammatory cytokines is increased in
VAT compared to SAT [34]. Finally, VAT is more involved than SAT in increasing leptin production
and reducing the circulating levels of adiponectin. In the light of this, it is easily understandable that
VAT contributes more to hepatic lipid accumulation than SAT [35].
Body fat distribution significantly differs between men and women [36–38]. Women have more
SAT, whereas men have more abdominal VAT [16,39–41]. Moreover, women also tend to store energy
in the gluteal–femoral adipose tissue, which is thought to be protective against the adverse effects of
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obesity [42,43]. This different pattern of body fat distribution may place men at greater risk of FL.
In agreement with this hypothesis, our results showed that male sex contributes to FLI. Interestingly,
we found that for each unit of adipose tissue, VAT and SAT contributed more in women than in men.
This result was also confirmed by the lower VAT cut-off values necessary for women to be at high FL
risk. This finding may have multiple reasons. Despite the fact that women generally store fat both at
abdominal and gluteal–femoral levels, about 40% of those aged 30–79 years store it predominantly at
the abdominal level [37,44], suffering from the same metabolic complication as men [45]. It is possible,
therefore, that in women with an upper-body obesity phenotype, abdominal fat depots contribute more
to FLI. A further reason could be related to the differences in alcohol intake between the sexes. Chronic
alcohol consumption causes the secretion of pro-inflammatory cytokines and reactive oxygen species,
which cause inflammation, apoptosis, and finally fibrosis of the liver cells [46]. Moreover, alcohol
abuse increases the risk of obesity and triglycerides and GGT levels [47,48], factors used to calculate
FLI, even if in the general population of Northern Italy no association was recently found between FL
and alcohol intake [6,49]. Compared to men, women are more likely to abstain from drinking alcoholic
beverages, drink less, and are less likely to engage in drinking problems [50]. Therefore, alcohol intake
may have a greater contribution in men compared to women in explaining FLI variability, reducing that
of a single unit of abdominal adipose tissue.
We found that FLI increased with increasing age, suggesting that the elderly have a higher risk of
developing FL, in agreement with previous investigations. However, the contribution of a single unit
of both abdominal fat depots to FLI diminished with increasing age. To confirm this, the predictive VAT
cut-offs of a FLI ≥ 60 increased with increasing age decade. Furthermore, in men aged 40 years or more
and in postmenopausal women, SAT had little or no predictive ability for a FLI ≥ 60, as demonstrated
by low AUC values and/or low sensitivity and specificity values of SAT cut-off. Aging is characterized
by an increase and redistribution of body fat in both sexes [51]. In particular, aging is accompanied by
a reduction of abdominal SAT and an increase in abdominal VAT [52]. Lower energy storage in SAT
could be the reason for its reduced contribution to FL in the elderly. In contrast, despite VAT being
notoriously associated with negative health outcomes, the clinical implications of an age-related shift
in VAT remain unclear [52]. Moreover, intra-muscular fat is also increased in aging [52,53]. These fat
deposits are commonly associated with metabolic derangements caused by lipotoxicity at the level of
the myocyte, which are thought to be implicated in the decline of peripheral glucose tolerance [53,54],
increasing the risk of FL [33]. This would lead to a reduction in the unitary contribution from VAT alone.
This was the first study to report sex- and age-related differences in the contribution of
ultrasound-measured VAT and SAT to FLI, as well as the first to identify sex- and age-specific
cut-off values of both abdominal fat depots predictive of high risk for FL. This information has been
obtained in a large sample of Caucasian overweight and obese subjects, allowing a better estimation of
contributions and predictive cut-offs. All ultrasound measurements of abdominal fat depots were taken
by the same physician, who has had long-term experience in using ultrasonography, thus avoiding
inter-operator measurement errors. Moreover, we recruited only Caucasian subjects, avoiding the
influence of ethnicity on both abdominal fat distribution and FL risk. On the other hand, this limits the
application of these findings to other ethnic groups. Another limitation is that we assessed abdominal
fat with ultrasonography, not with a gold standard imaging technique. However, evidence has shown
a good correlation between ultrasound measurements of abdominal fat thicknesses and areas by CT or
MRI [19]. Moreover, we used FLI to identify subjects at high FL risk, not ultrasonography to diagnose
FL. Nevertheless, FLI has been found to be able to predict FL in several populations [3–5]. Finally,
we did not take into account the patients’ dietary habits, a factor known to be associated with both
abdominal adipose tissue [55] and FL risk [56], and which can be different between men and women
and change with age [57]. Therefore, future studies might address the ability of diet to mitigate the
effect of abdominal adipose tissue on FL.
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5. Conclusions
In conclusion, abdominal adipose tissue depots are associated with FLI, but their contribution is
sex- and age-dependent. Sex- and age-specific cut-off values of ultrasound-measured VAT and SAT
could be useful both clinically and in research field to screen overweight and obese populations to
identify subjects at risk for fatty liver disease. However, our findings need further validation against a
fatty liver diagnosis made through imaging techniques and replicated in external populations.
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